GHRP-2
Sourcing GuideSourcing GHRP-2 from research-grade vendors requires the QC framework that governs any peptide procurement: certificate of analysis review, lot-specific verification, third-party laboratory issuance, and — critically — endotoxin testing for injectable material. A second-generation GHRP with stronger GH-releasing effect than GHRP-6, but more prolactin and cortisol elevation than ipamorelin. The three-tier vendor market (pharmaceutical-grade compounded, reputable research-grade, grey-market) is described below.
Key Takeaways
Procurement lens: GHRP-2 sourcing requires lot-specific COA, HPLC purity ≥98%, mass spec confirmation matching 817 Da. Mechanism: Selective ghrelin/GHSR receptor agonist on pituitary somatotrophs. Storage: lyophilised at -20°C for 18-24 months; reconstituted at 4°C for 14-28 days. Vendor tier: pharmaceutical-grade compounded > reputable research-grade > grey-market (3-5x cost differential; quality differential substantially larger). Sourcing-validated stack partners: BPC-157, TB-500, GHK-Cu.
Selective ghrelin/GHSR receptor agonist on pituitary somatotrophs. Stimulates a pulsatile GH release. Mildly raises ACTH/cortisol and prolactin compared to ipamorelin. Quality control discipline for GHRP-2 starts with mechanism understanding: which assays detect counterfeits, which impurities matter for the intended use, and which storage conditions preserve activity. The subsections work through HPLC purity, COA evaluation, reconstitution protocol, and vendor selection.
Reconstitution and storage protocols
GHRP-2 is typically supplied lyophilised in glass vials for reconstitution with bacteriostatic water. Standard reconstitution: dissolve at 1–2 mg/mL, store reconstituted material at 4°C, and use within 14–28 days. Avoid freeze-thaw cycles of reconstituted material. Lyophilised storage at −20°C extends shelf life to 18–24 months for most peptides in this class.
Vendor tier comparison and price discipline
Three vendor tiers operate in the GHRP-2 market: pharmaceutical-grade compounded prescription (physician-supervised, full COA, ICP-MS where relevant, highest cost), reputable research-chemical vendors (full COA, lot-specific, mid-tier cost), and grey-market unverified sources (template or absent COA, unverifiable supply chain, lowest cost). The price differential between tiers is roughly 3–5x; the quality differential is substantially larger and concentrated in the bottom tier.
COA evaluation and red flags
Acceptable GHRP-2 certificates of analysis specify: (1) lot number matching the vial, (2) HPLC purity with chromatographic trace, (3) mass spec confirmation, (4) endotoxin testing for SubQ-route use, and (5) issuance from an accredited third-party laboratory. Template COAs that cannot be traced to a specific lot, COAs missing endotoxin data for injectable material, and COAs issued by the vendor's own laboratory rather than a third party are all sourcing red flags.
Sourcing GHRP-2 for gmp vs research grade use requires the same QC discipline as any peptide procurement: lot-specific COA, HPLC purity ≥98%, mass spec confirmation, endotoxin testing for injectable routes. Application-specific use does not relax the sourcing standard.
For users targeting storage protocol, the sourcing question is whether the chosen vendor consistently delivers analytical-spec material across lots. Repeated re-orders from the same vendor with mid-cycle COA spot-checks is the procurement pattern that catches lot drift before it affects results.
Pharmaceutical-grade compounded GHRP-2 is the lowest-risk sourcing path for bac water sourcing use where the route permits, particularly for users with clinical supervision. Research-grade material from accredited vendors is the practical alternative; grey-market sourcing is not appropriate for this application.
Sourcing GHRP-2 for reconstitution guide use requires the same QC discipline as any peptide procurement: lot-specific COA, HPLC purity ≥98%, mass spec confirmation, endotoxin testing for injectable routes. Application-specific use does not relax the sourcing standard.
| Goal | Route | Dose | Cycle |
|---|---|---|---|
| Standard protocol | SubQ | 100-300 mcg | 8–12 weeks on / 4 weeks off |
| Conservative starter | SubQ | 60-300 mcg | 4–6 weeks initial cycle |
| Sourcing Guide focus | SubQ | 100-300 mcg | 2-3x daily SubQ |
| Maintenance phase | SubQ | 70-300 mcg | Ongoing with periodic pauses |
Dose timing for GHRP-2 is important relative to food and training given the short half-life. Consistency through the cycle is more important than the precise clock time of individual doses.
GHRP-2 stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from experienced peptide buyers.
- GHRP-2 + BPC-157: Upregulates VEGFR2 to promote angiogenesis and activates the FAK-paxillin pathway for accelerated tissue repair. Pairs naturally with GHRP-2's mechanism in sourcing / quality / procurement protocols.
- GHRP-2 + TB-500: Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool. Pairs naturally with GHRP-2's mechanism in sourcing / quality / procurement protocols.
- GHRP-2 + GHK-Cu: GHK chelates copper(II) and acts as a transcriptional modulator: published microarray data show it influences over 4,000 human genes including resetting expression patterns toward younger cellular phenotypes. Pairs naturally with GHRP-2's mechanism in sourcing / quality / procurement protocols.
- GHRP-2 + Ipamorelin: Highly selective GHSR1a agonist. Pairs naturally with GHRP-2's mechanism in sourcing / quality / procurement protocols.
More prolactin/cortisol effect than ipamorelin. Pair with GHRH for synergy.
Lens-specific safety considerations for sourcing / quality / procurement use of GHRP-2: More prolactin/cortisol effect than ipamorelin. Pair with GHRH for synergy. Additional sourcing / quality / procurement monitoring at baseline and 6–8 week follow-up is appropriate.
| Compound | Profile | Onset | Best For |
|---|---|---|---|
| GHRP-2 | Growth hormone releasing peptide | ~15-60 min | Sourcing Guide |
| BPC-157 | Stable gastric pentadecapeptide | ~4 hr (oral) | Accelerated tendon, ligament, and gut tissue repair via VEGFR2-driven angiogenesis and FAK-paxillin signalling |
| TB-500 | Synthetic thymosin β4 fragment | ~2-3 days | A 17-amino-acid synthetic fragment of thymosin β4 with actin-sequestering activity — drives cell migration, tissue repair, and broad regenerative effects |
| GHK-Cu | Tripeptide-copper complex | ~30 min plasma | A naturally occurring tripeptide-copper complex that declines with age and is studied for its broad effects on wound healing, skin remodelling, and gene expression |
| Ipamorelin | Selective GHRP / ghrelin mimetic | ~2 hr | The most selective ghrelin-receptor agonist among the GHRPs — stimulates GH release with minimal effect on cortisol, prolactin, or appetite |
Storage protocol?
Vendor red flags?
Reconstitution best practices?
Lot variability across orders?
What is GHRP-2?
Should I cycle GHRP-2?
Start a GHRP-2 Protocol
Alukard provides GMP-certified physician-supervised sourcing with GMP-certified GHRP-2 and Pharmaceutical-grade compounds with full COA documentation.
Get ProtocolQuick Facts
- Molecular weight
- 817 Da
- Sequence length
- 6 aa
- Half-life
- ~15-60 min
- WADA
- Banned (S2)
- FDA
- Approved in Japan for GH stimulation testing only
Stack Partners
All sourcing / quality / procurement applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for GHRP-2 unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.
Start Your Sourcing / Quality / Procurement Protocol for GHRP-2
Alukard provides GMP-certified physician-supervised sourcing with Pharmaceutical-grade compounds with full COA documentation.
HIPAA Compliant · GMP Certified · Physician Supervised